SHE:002873 Revenue

In the year 2025, Guiyang Xintian Pharmaceutical had annual revenue of 749.72M CNY, down -12.57%. Guiyang Xintian Pharmaceutical had revenue of 191.09M in the quarter ending December 31, 2025, a decrease of -2.86%.

Revenue

749.72M

Revenue Growth

-12.57%

P/S Ratio

3.00

Revenue / Employee

445.73K

Employees

1,682

Market Cap

2.25B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	749.72M	-107.83M	-12.57%
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Universal Biotech	1.07B
Shandong Sito Bio-technology	954.76M
Zhejiang East Asia Pharmaceutical	831.56M
Guangdong VTR Bio-Tech	830.87M
Jilin Jian Yisheng Pharmaceutical	640.17M
Hubei Goto Biopharm	626.28M
Suzhou Fushilai Pharmaceutical	439.57M
Shanghai Hile Bio-Technology	246.35M

Revenue Rankings